Kalbe Farma

PT Kalbe Farma Tbk is a pharmaceutical, healthcare and nutrition company in North Jakarta, established in 1966. The Company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).[1]

PT Kalbe Farma Tbk
FoundedSeptember 10, 1966
HeadquartersJakarta, Indonesia
Area served
Cambodia, Malaysia, Myanmar, Philippines, Thailand, Vietnam, Sri Lanka, South Africa and Nigeria
Key people
RevenueIncrease Rp 15.678 trillion (YTD Q3 2018)
Increase Rp 1.834 trillion (YTD Q3 2018)
Total assetsIncrease Rp 17.531 trillion (YTD Q3 2018)
Number of employees
17,000 (YTD Q3 2018)

Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen and Extra Joss.

Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.


Kalbe Farma was founded on September 10, 1966 by 6 siblings, Khouw Lip Tjoen, Khouw Lip Hiang, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boen, Boenjamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.

In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.[2]


  1. ^ Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020. CS1 maint: discouraged parameter (link)
  2. ^ "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.

External linksEdit